The three different classes of lignin-derived ILs were prepared using methods previously optimized for similar compounds.
3.2.1. General procedure for the synthesis of imidazolium lignin-based ILs
The imidazolium-based ILs were synthesized from a methyl carbonate precursor in accordance with the procedure developed for carboxylated ILs by Mero et al. [
18]. The proper phenolic acid (1 equiv.) was added to a commercially available methanolic solution of the methyl carbonate IL. The concentration of methylcarbonate IL in methanol solution was previously determined by volumetric titration using a standard 0.1 M HCl solution (Eutech pH meter, pH 700, calibrated with three standard buffer solutions at pH 4.01, 7.00 and 10.00). The resulting mixture was stirred for 2 h at room temperature and the reaction solvent was evaporated under reduced pressure at 45 °C for 3 h to recover the target compounds in quantitative yield. The structure of the compounds was confirmed by
1H and
13C-NMR and the spectra are reported in the supporting information.
Fig_label.
Synthetic steps for [Emim]Gal.
Fig_label.
Synthetic steps for [Emim]Gal.
3-ethyl-1-methyl-1H-imidazol-3 ium gallate ([Emim]Gal).
The preparation of [Emim]Gal (99% yield, light yellow solid), whose synthetic pathway is showed in Fig-label, was performed according to the general procedure for imidazolium-based ILs. 1H-NMR (400 MHz, MeOD) δ(ppm) s 8.78 (s, 1H, C(2)H imidazolium), 7.50 and 7.43 (2d, 2H, C(4-5)H imidazolium), 6.98 (s, 2H, 2X C(orto)H gallic), 4.15 (q, 2H, NCH2CH3 chain), 3.83 (s, 3H, NCH3), 1.45 (t, 3H, NCH2CH3); 13C-NMR (100 MHz, MeOD) δ (ppm) 175.6 (COO-, gallic), 146.1 (C-3 and C-5, gallic), 137.4 (C-4, gallic), 136.8 (C-2 imidaz), 129.6 (C-1, gallic), 124.8, 123.1 (C-4 and C-5, imidaz), 110.0 (C-2 and C-6, gallic), 45.94 (NCH2 CH3), 36.36 (NCH3), 15.44 (NCH2 CH3).
3-ethyl-1-methyl-1H-imidazol-3-ium syringate ([Emim]Syr).
The preparation of [Emim]Syr (99% yield, brown solid) was performed according to the general procedure for imidazolium-based ILs. 1H-NMR (400 MHz, MeOD) δ(ppm) s 8.92 (s, 1H, C(2)H imidazolium), 7.63 and 7.55 (2d, 2H, C(4-5)H imidazolium), 7.34 (s, 2H, 2 X C(orto)H syring), 4.24 (q, 2H, NCH2CH3 chain), 3.92 (s, 3H, NCH3), 3.89 (s, 6H, 2X(OCH3)), 1.53 (t, 3H, NCH2CH3); 13C-NMR (100 MHz, MeOD) δ (ppm) 175.3 (COO-, syring), 148.7 (C-3 and C-5, syring), 140.23 (C-4, syring), 137.7 (C-2 imidaz), 128.9 (C-1, gallic), 124.9, 123.3 (C-4 and C-5, imidaz), 108.2 (C-2 and C-6, syring), 56.7 (2x (OCH3), syring), 45.99 (NCH2 CH3), 36.38 (NCH3), 15.52 (NCH2 CH3).
3-ethyl-1-methyl-1H-imidazol-3-ium vanillate ([Emim]Van).
The preparation of [Emim]Van (99% yield, brown liquid) was performed according to the general procedure for imidazolium-based ILs. 1H-NMR (400 MHz, MeOD) δ(ppm) s 8.91 (s, 1H, C(2)H imidazolium), 7.60 and 7.53 (2d, 2H, C(4-5)H imidazolium), 7.59 (d, 1H, C(2)H van), 7.49 (dd, 1H, C(6)H van), 6.76 (d, 1H, C(5)H), 4.23 (q, 2H, NCH2CH3 chain), 3.90 (s, 3H, NCH3), 3.89 (s, 3H, OCH3), 1.51 (t, 3H, NCH2CH3); 13C-NMR (100 MHz, MeOD) δ (ppm) 175.4 (COO-, van), 151.2 (C-4, van), 148.4 (C-3, van), 137.4 (C-2 imidaz), 130.1 (C-1, van), 124.8, 123.2 (C-4 and C-5, imidaz), 124.2 (C-6, van), 115.5 (C-5, van), 114.1 (C-2, van), 56.3 (OCH3), syring), 45.94 (NCH2 CH3), 36.35 (NCH3), 15.49 (NCH2 CH3).
3.2.2. General procedure for the synthesis of cholinium lignin-based ILs
Choline-based ILs have been prepared from a commercially available aqueous solution of choline hydroxide (ChOH). Choline hydroxide (ChOH) solution was titrated with aqueous HCl 1 M, giving the exact percentage of ionic liquid in water. An equimolar amount of the proper phenolic acid was added to the titrated solution and the mixture stirred for 1 h. Finally, the solvent was removed under vacuum at 60 °C for 8 h to obtain the corresponding reaction products, all of which were light yellow. The structure of the compounds was checked by
1H and
13C-NMR and the spectra, reported in the supporting information, agreed with those reported in the literature [
19].
Fig_label.
Synthetic steps for Cholinum gallate [Chol]Gal.
Fig_label.
Synthetic steps for Cholinum gallate [Chol]Gal.
The preparation of [Chol]Gal (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs.
1H NMR (400 MHz, MeOD): δ 7.05 (s, 2H, H-2 e H-6), 4.04-3.99 (m, 2H, NC
H2CH
2OH), 3.50 – 3.46 (m, 2H, NCH
2C
H2OH), 3.20 (s, 9H, N(C
H3)
3)).
13C NMR (100 MHz, MeOD) δ 175.4 (s, COO), 145.6 (C-3 e C-5), 136.9 (C-4), 129.5 (C-1), 110.2 (C-2 e C-6), 68.91 (N
CH
2CH
2OH), 56.89 (NCH
2CH
2OH), 54.91, 54.87, 54.84 (N(
CH
3)
3).
1H NMR and
13C NMR data agree with those reported in literature[
20].
Trimethyl-β-hydroxyethyl-ammonium syringate ([Chol]Syr)
The preparation of [Chol]Syr (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs.
1H NMR (400 MHz, MeOD): δ 7.35 (d, 2H, H-2 and H-6), 4.01-3.97 (m, 2H, NC
H2CH
2OH), 3.89 (s, 6H, 2x(OC
H3)), 3.49 – 3.44 (m, 2H, NCH
2C
H2OH), 3.19 (s, 9H, N(C
H3)
3)).
13C NMR (100 MHz, MeOD) δ 175.1 (
COO), 148.4 (
COH-4), 139.2 (2x (
COCH
3)), 129.6 (
CCOO-1), 108.1 (C-6), 69.05 (N
CH
2CH
2OH), 57.04 (NCH
2CH
2OH), 56.69 (2x(O
CH
3)), 54.70, 54.67, 54.63 (N(
CH
3)
3).
1H NMR and
13C NMR data AGREEwith those reported in literature[
19].
Trimethyl-β-hydroxyethyl-ammoniumvanillate ([Chol]Van)
The preparation of [Chol]Van (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs.
1H NMR (400 MHz, MeOD): δ 7.61 (d, 1H, H-2), 7.50 (dd, 1H, H-6), 6.79 (d, 1H, H-5), 4.01 – 3.96 (m, 2H, NCH
2C
H2OH), 3.90 (s, 3H, OC
H3), 3.48-3.44 (m, 2H, NC
H2CH
2OH), 3.19 (s, 9H, N(
CH3)
3).
13C NMR (100 MHz, MeOD) δ 175.3 (
COO), 150.28 (
COH-4), 148.1 (
COCH
3-3), 130.7 (
CCOOH), 124.2 (C-6), 115.30 (C-5), 114.1 (C-2), 69.04 (N
CH
2CH
2OH), 57.02 (NCH
2CH
2OH), 56.32 (O
CH
3), 54.69, 54.66, 54.62 (N(
CH
3)
3).
1H NMR and
13C NMR data agree with those reported in literature [
20].
3.2.3. General procedure for the synthesis of protic lignin-based ILs
An equimolar amount of phenolic acid was added to 1,5-diazabicyclo[5.4.0]undec-7-ene [DBU] at 0 °C without the addition of solvent. The reaction was mixed at 0 °C for 5 minutes and then the mixture was returned to room temperature. The structure of the compounds was confirmed by 1H and 13C-NMR and the spectra are reported in the supporting information.
Fig_label.
Synthetic steps for [DBU]Gal.
Fig_label.
Synthetic steps for [DBU]Gal.
1,5-diazabicyclo[5.4.0]undec-7-eneium gallate ([DBU]Gal).
The preparation of [DBU]Gal (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs. 1H NMR (400 MHz, MeOD): δ 7.03 (s, 2H, H-2 e H-6), 3.58–3.53 (m, 2H, H-6 DBU), 3.50 (t, 2H, H-4 DBU), 3.32 (t, 2H, H-2 DBU) 2.66–2.61 (m, 2H, H-10 DBU), 2.00 (sept, 2H, H-2 DBU) 1.81–1.61 (m, 6H, H-7,8,9 DBU). 13C NMR (100 MHz, MeOD) δ 175.4 (COO), 167.5 (N-C=N), 145.9 (C-3 e C-5), 137.8 (C-4), 129.6 (C-1), 110.1 (C-2 e C-6), 55.37 (C-6 DBU), 49.54 (C-4 DBU), 39.34 (C-2 DBU), 33.70 (C-10 DBU), 29.91 (C-7 DBU), 27.45 (C-8 DBU), 24.91 (C-9 DBU), 20.41 (C-3 DBU).
1,5-diazabicyclo[5.4.0]undec-7-eneium syringate ([DBU]Syr).
The preparation of [DBU]Syr (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs. 1H NMR (400 MHz, MeOD): δ 7.35 (s, 2H, H-2 e H-6), 3.89 (s, 3H, OCH3), 3.61–3.54 (m, 2H, H-6 DBU), 3.52 (t, 2H, H-4 DBU), 3.34 (t, 2H, H-2 DBU) 2.70–2.613 (m, 2H, H-10 DBU), 2.02 (sept, 2H, H-2 DBU) 1.83–1.64 (m, 6H, H-7,8,9 DBU). 13C NMR (100 MHz, MeOD) δ 175.1 (COO), 167.5 (N-C=N), 148.4 (C-3 e C-5), 139.1 (C-4), 129.7 (C-1), 108.1 (C-2 e C-6), 56.71 (2x(OCH3)), 55.35 (C-6 DBU), 49.55 (C-4 DBU), 39.34 (C-2 DBU), 33.70 (C-10 DBU), 29.92 (C-7 DBU), 27.46 (C-8 DBU), 24.96 (C-9 DBU), 20.41 (C-3 DBU).
1,5-diazabicyclo[5.4.0]undec-7-eneium vanillate ([DBU]Van).
The preparation of [DBU]Van (99% yield, light yellow solid) was performed according to the general procedure for imidazolium-based ILs. 7.60 (d, 1H, H-2), 7.49 (dd, 1H, H-6), 6.77 (d, 1H, H-5), 3.90 (s, 3H, OCH3), 3.60–3.55 (m, 2H, H-6 DBU), 3.51 (t, 2H, H-4 DBU), 3.33 (t, 2H, H-2 DBU) 2.69–2.63 (m, 2H, H-10 DBU), 2.01 (sept, 2H, H-2 DBU) 1.80–1.61 (m, 6H, H-7,8,9 DBU). 13C NMR (100 MHz, MeOD) δ 175.2 (COO), 167.5 (N-C=N), 150.0 (COH-4), 148.1 (COCH3-3), 130.7 (CCOOH), 124.2 (C-6), 115.20 (C-5), 114.2 (C-2), 56.35 (2x(OCH3)), 55.32 (C-6 DBU), 49.53 (C-4 DBU), 39.32 (C-2 DBU), 33.65 (C-10 DBU), 29.91 (C-7 DBU), 27.45 (C-8 DBU), 24.91 (C-9 DBU), 20.40 (C-3 DBU).